Stockholders' Equity (Tables)

12 Months Ended

Dec. 31, 2018

Stockholders' Equity Note [Abstract]

Schedule of share-based compensation, stock options, activity

	Shares Underlying Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (years)		Aggregate Intrinsic Value
Outstanding at January 1, 2017		-		$	-		-		-
Granted		-			-		-		-
Outstanding at December 31, 2017		-			-		-		-
Acquired in Merger		133,711			36.42		3.88		-
Granted		214,239			5.58		9.72		-
Forfeited		(45,178	)		11.64		-		-
Outstanding at December 31, 2018		302,772		$	18.3		7.20		-

Schedule of share-based compensation

	Year ended December 31,
	2018		2017
Research and development	$	12,636	$	-
Selling, general and administrative		3,780,919		708,998
Stock-based compensation from discontinued operations		74,109		-
Total	$	3,867,664	$	708,998

Schedule of share-based payment award, stock options, valuation assumptions

Fair value of common stock	$1.62-$13.26
Expected volatility	118.10% - 151.79%
Dividend yield	0%
Risk-free interest	2.79% - 3.00%
Expected life (years)	5.13 - 5.50

Schedule of common stock warrant activity

	Number of Warrants			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (years)
January 1, 2017		-		$	-		-
Granted, Merger Warrants		146,358			59.04		4.50
Outstanding, December 31, 2017		146,358			59.04		4.50
Acquired, H-1 warrants		50,744			29.04		1.55
Acquired, H-3 warrants		14,001			33.12		3.25
Granted, H-4 warrants		447,383			3.60		4.18
Granted, I warrants		73,178			13.80		2.30
Granted, Reload warrants		260,116			6.00		2.60
Granted, K warrants		277,778			0.06		*
Exercised, H-4 warrants		(260,116	)		3.60		-
Retired, Merger Warrants		(146,358	)		59.04		-
Outstanding, December 31, 2018		863,084		$	6.00		2.51